| Control of microglial neurotoxicity by the fractalkine receptor AE Cardona, EP Pioro, ME Sasse, V Kostenko, SM Cardona, IM Dijkstra, ... Nature neuroscience 9 (7), 917-924, 2006 | 1726 | 2006 |
| Genome-wide analyses identify KIF5A as a novel ALS gene A Nicolas, KP Kenna, AE Renton, N Ticozzi, F Faghri, R Chia, ... Neuron 97 (6), 1267-1288, 2018 | 592 | 2018 |
| Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis JO Johnson, EP Pioro, A Boehringer, R Chia, H Feit, AE Renton, ... Nature neuroscience 17 (5), 664-666, 2014 | 521 | 2014 |
| Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes PM Andersen, KB Sims, WW Xin, R Kiely, G O'Neill, J Ravits, E Pioro, ... Amyotrophic lateral sclerosis and other motor neuron disorders 4 (2), 62-73, 2003 | 374 | 2003 |
| Distribution of nerve growth factor receptor-like immunoreactivity in the adult rat central nervous system. Effect of colchicine and correlation with the cholinergic system—II … EP Pioro, AC Cuello Neuroscience 34 (1), 89–110, 1990 | 350 | 1990 |
| Distribution of nerve growth factor receptor-like immunoreactivity in the adult rat central nervous system. Effect of colchicine and correlation with the cholinergic system—I … EP Pioro, AC Cuello Neuroscience 34 (1), 57-87, 1990 | 350 | 1990 |
| Amyotrophic lateral sclerosis H Mitsumoto Current Science and Approaches to Therapy, 2005 | 343 | 2005 |
| A clinical trial of creatine in ALS JM Shefner, ME Cudkowicz, D Schoenfeld, T Conrad, J Taft, M Chilton, ... Neurology 63 (9), 1656-1661, 2004 | 339 | 2004 |
| Subcutaneous IGF-1 is not beneficial in 2-year ALS trial EJ Sorenson, AJ Windbank, JN Mandrekar, WR Bamlet, SH Appel, ... Neurology 71 (22), 1770-1775, 2008 | 280 | 2008 |
| Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions S Narayanan, L Fu, E Pioro, N De Stefano, DL Collins, GS Francis, ... Annals of neurology 41 (3), 385-391, 1997 | 271 | 1997 |
| A randomized controlled trial of resistance exercise in individuals with ALS VD Bello-Haas, JM Florence, AD Kloos, J Scheirbecker, G Lopate, ... Neurology 68 (23), 2003-2007, 2007 | 263 | 2007 |
| Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III P Kaufmann, JLP Thompson, G Levy, R Buchsbaum, J Shefner, ... Annals of Neurology: Official Journal of the American Neurological …, 2009 | 262 | 2009 |
| A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis ME Cudkowicz, JM Shefner, DA Schoenfeld, RH Brown Jr, H Johnson, ... Neurology 61 (4), 456-464, 2003 | 253 | 2003 |
| Dextromethorphan plus ultra Low‐Dose quinidine reduces pseudobulbar affect EP Pioro, BR Brooks, J Cummings, R Schiffer, RA Thisted, D Wynn, ... Annals of neurology 68 (5), 693-702, 2010 | 224 | 2010 |
| Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo EP Pioro, JP Antel, NR Cashman, DL Arnold Neurology 44 (10), 1933-1933, 1994 | 215 | 1994 |
| Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy PM Matthews, E Pioro, S Narayanan, ND Stefano, L Fu, G Francis, J Antel, ... Brain 119 (3), 715-722, 1996 | 207 | 1996 |
| Defining and diagnosing involuntary emotional expression disorder JL Cummings, DB Arciniegas, BR Brooks, RM Herndon, EC Lauterbach, ... CNS spectrums 11 (S6), 1-11, 2006 | 198 | 2006 |
| Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis S Bandres‐Ciga, AJ Noyce, G Hemani, A Nicolas, A Calvo, G Mora, ... Annals of neurology 85 (4), 470-481, 2019 | 167 | 2019 |
| 1H-MRS evidence of neurodegeneration and excess glutamate glutamine in ALS medulla EP Pioro, AW Majors, H Mitsumoto, DR Nelson, TC Ng Neurology 53 (1), 71-71, 1999 | 165 | 1999 |
| Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS M Benatar, L Zhang, L Wang, V Granit, J Statland, R Barohn, A Swenson, ... Neurology 95 (1), e59-e69, 2020 | 157 | 2020 |
claudio cuelloProfessor and Charles E Frosst/Merck Chair in Pharmacology在 mcgill.ca 的电子邮件经过验证
